The global escalation of metabolic disorders has transformed obesity from a secondary health concern into a primary clinical challenge, necessitating a more sophisticated approach to pharmaceutical intervention. While the ultimate goal of any therapeutic is successful human application, the high rate of attrition in clinical trials underscores the critical need for a robust preclinical foundation. This is where Obesity Models serve as the indispensable bridge, allowing researchers to simulate th...
18 views
0 likes